Integrating hypertension and cardiovascular disease care into existing HIV service package in botswana (intercare)-statin sub-study
Active Project Grant Awarded Last action
- Award ID
- R01HL182509
- Recipient
-
University Of Botswana UEI KK23S78JK1A8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,451,057
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 24% complete
- Place of performance
- Botswana
Award details come from USAspending.gov.
Description
- Abstract
- While botswana has attained the unaids 95-95-95 target for HIV treatment and is the first country with severe HIV epidemic to reach the milestone of elimination of mother-to-child HIV transmission, there is a growing concern about long-term risk of non-communicable diseases among people living with HIV (PWH). In 2022, a large international study (that included botswana) focussed on prevention of heart attacks and strokes, called reprieve, revealed that use of cholesterol lowering medicines (statins) such as pitavastatin© can reduce the risk of heart attacks and stroke among PWH. The US department of human and health services has since released a guideline for use of statins among PWH. Similarly, the british HIV clinicians society issued a similar, but easier to implement statin guideline for PWH. Thus, in the proposed research, we will develop and test new strategies that target PWH plus diagnosis of hypertension to be initiated on statin therapy. Our proposed study will leverage a study of PWH and hypertension in botswana. The program will be developed in collaboration with policy makers, healthcare providers, community leaders, patients, etc in botswana. Following initial engagement with different informants, we will then use the new implementation strategy to conduct a type 2 hybrid multi-component cluster randomized trial to optimize evidence based implementation (EBI) uptake of statin therapy.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $32,006 | |
| Amendment | $462,384 | |
| Amendment | $32,006 | |
| Original award | $462,277 |
Quick answers
Who received award R01HL182509?
R01HL182509 was awarded to University Of Botswana by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2025.
How much is award R01HL182509 worth?
$1,451,057 has been obligated on R01HL182509.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award